| 摘要 |
The present invention relates to the field of in vitro diagnostics related to diabetes. In particular means and methods for the prediction of the risk of a patient to suffer from type 2 diabetes and for the diagnosis of its complication are disclosed. The invention employs cardiac troponins, GDF-15, natriuretic peptides, H-FABP and variants of the aforementioned peptides as biomarkers.
|
